Lojuxta Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

lojuxta

amryt pharmaceuticals dac - lomitapide - hypercholesterolemia - lipid modifying agents - lojuxta is indicated as an adjunct to a low‑fat diet and other lipid‑lowering medicinal products with or without low-density-lipoprotein (ldl) apheresis in adult patients with homozygous familial hypercholesterolaemia (hofh). genetic confirmation of hofh should be obtained whenever possible. other forms of primary hyperlipoproteinaemia and secondary causes of hypercholesterolaemia (e.g. nephrotic syndrome, hypothyroidism) must be excluded.,

Kengrexal Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

kengrexal

chiesi farmaceutici s.p.a. - cangrelor - acute coronary syndrome; vascular surgical procedures - antithrombotic agents - kengrexal, co-administered with acetylsalicylic acid (asa), is indicated for the reduction of thrombotic cardiovascular events in adult patients with coronary artery disease undergoing percutaneous coronary intervention (pci) who have not received an oral p2y12 inhibitor prior to the pci procedure and in whom oral therapy with p2y12 inhibitors is not feasible or desirable.

Non-Drowsy Sudapro Head Cold 200mg / 30mg Film-coated Tablets Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

non-drowsy sudapro head cold 200mg / 30mg film-coated tablets

mcneil healthcare (ireland) ltd - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200/30 milligram(s) - other cold preparations

Non-Drowsy Sudapro Head Cold 200mg / 30mg Film-coated Tablets Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

non-drowsy sudapro head cold 200mg / 30mg film-coated tablets

johnson & johnson (ireland) limited - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200 mg/30 milligram(s) - other cold preparations